Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Pain 6Neoplasms 3Neoplasm Metastasis 2Cancer Pain 2Breast Neoplasms 2Wounds and Injuries 1Pleural Effusion, Malignant 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Leiomyoma 1Ileus 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Morphine × Clear all
NCT05800834 2023-09-28

MorphineGEL

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
106 enrolled
BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT02044302 2017-04-10

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

Yale University

Phase 2 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡